PETS · NASDAQ
PetMed Express (PETS) Stock Price & Fundamentals
PetMed Express (PETS) closed at $692.49 on Oct 9, 2026, down 0.34% from the previous close of $694.82.
Share price, past year
1Y −0.61%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $692.49 |
| Sep 30, 2026 | $721.53 |
| Aug 31, 2026 | $718.41 |
| Jul 31, 2026 | $699.95 |
| Jun 30, 2026 | $677.21 |
| May 29, 2026 | $646.31 |
| Apr 30, 2026 | $650.94 |
| Mar 31, 2026 | $641.84 |
| Feb 27, 2026 | $630.60 |
| Jan 30, 2026 | $613.61 |
| Dec 31, 2025 | $643.70 |
| Nov 28, 2025 | $670.85 |
| Oct 31, 2025 | $679.79 |
Key statistics
- Market cap
- $15.01B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.37
- Revenue (TTM)
- $168.86M
- Net income (TTM)
- −$29.28M
- Shares outstanding
- 21.7M
- Dividend yield
- —
- 52-week range
- $611.42 – $727.67
PetMed Express's market cap is $15.01B, based on a share price of $692.49 and 21.7M shares outstanding as of Jun 30, 2026.
Financials
PetMed Express reported revenue of $179.02M for fiscal 2026, down 21.13% from fiscal 2025.
PetMed Express reported a net loss of $57.29M in fiscal 2026.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended Mar 31, 2026 | $179.02M | −21.1% | −$57.29M | −32.0% | −$2.74 | −$33.01M |
| FY2025ended Mar 31, 2025 | $226.97M | −17.2% | −$6.27M | −2.8% | −$0.30 | −$395.00K |
| FY2024ended Mar 31, 2024 | $274.10M | +10.7% | −$7.46M | −2.7% | −$0.37 | −$194.00K |
| FY2023ended Mar 31, 2023 | $247.57M | −9.1% | $5.14M | 2.1% | $0.25 | $22.54M |
| FY2022ended Mar 31, 2022 | $272.28M | −10.3% | $18.72M | 6.9% | $0.92 | $16.75M |
| FY2021ended Mar 31, 2021 | $303.58M | +6.9% | $23.92M | 7.9% | $1.19 | $37.64M |
| FY2020ended Mar 31, 2020 | $284.13M | +0.3% | $25.85M | 9.1% | $1.29 | $36.53M |
| FY2019ended Mar 31, 2019 | $283.42M | +3.5% | $37.74M | 13.3% | $1.84 | $44.52M |
| FY2018ended Mar 31, 2018 | $273.80M | +9.9% | $37.28M | 13.6% | $1.82 | $36.68M |
| FY2017ended Mar 31, 2017 | $249.18M | — | $23.82M | 9.6% | $1.17 | $36.60M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2027ended Jun 30, 2026 | $41.02M | −$6.15M | −$0.28 |
| Q4 FY2026ended Mar 31, 2026 | $42.82M | −$4.06M | −$0.18 |
| Q3 FY2026ended Dec 31, 2025 | $40.66M | −$10.55M | −$0.50 |
| Q2 FY2026ended Sep 30, 2025 | $44.36M | −$8.52M | −$0.41 |
| Q1 FY2026ended Jun 30, 2025 | $51.18M | −$34.15M | −$1.65 |
| Q4 FY2025ended Mar 31, 2025 | $50.76M | −$11.64M | −$0.56 |
| Q3 FY2025ended Dec 31, 2024 | $51.96M | −$707.00K | −$0.03 |
| Q2 FY2025ended Sep 30, 2024 | $58.04M | $2.33M | $0.11 |
Company profile
- Name
- PetMed Express, Inc.
- Ticker
- PETS
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Retail-Drug Stores and Proprietary Stores
- Headquarters
- 420 South Congress Avenue, Delray Beach, FL 33445
- Incorporated in
- FL
- Fiscal year ends
- March
- SEC CIK
- 0001040130
Recent SEC filings
- Sep 28, 2026
- Sep 21, 2026
- Sep 17, 2026
- Aug 13, 2026
- Aug 13, 2026
- Aug 12, 2026
- Jul 23, 2026
- Jun 26, 2026
Frequently asked questions
What is PetMed Express's stock price?
PetMed Express (PETS) closed at $692.49 on Oct 9, 2026, down 0.34% from the previous close of $694.82.
What is PetMed Express's market cap?
PetMed Express's market cap is $15.01B, based on a share price of $692.49 and 21.7M shares outstanding as of Jun 30, 2026.
How much revenue does PetMed Express make?
PetMed Express reported revenue of $179.02M for fiscal 2026, down 21.13% from fiscal 2025.
Does PetMed Express pay a dividend?
Yes. PetMed Express declared $0.00 per share in dividends for fiscal 2026.
Sources and methodology
Fundamentals come from PetMed Express, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures